In the current study, the RNF213 p.R4810K mutation significantly increased the risk of cerebrovascular events (symptomatic infarction or hemorrhage) in MCAD in both patient-based and hemisphere-based analyses. This evidence concerns the gene RNF213 and hemorrhage.